Jury Trial Scheduled for 2024 in Ripple’s Case against SEC

Judge Torres has announced that the lawsuit between the U.S. Securities and Exchange Commission (SEC) and Ripple Labs will proceed to a jury trial in the second quarter of 2024. This development has significant implications for the cryptocurrency market.

The key dates set by Judge Torres for the trial are as follows:

– August 23, 2023: Both parties must submit any blackout dates for the trial.
– December 4, 2023: Deadline for the submission of motions in limine. Oppositions to these motions should be submitted by December 18, 2023.
– December 4, 2023: Parties are required to submit all pretrial filings and deliver one copy of each documentary exhibit to the court. Email copies of these submissions should also be sent to [email protected]
– A final pretrial conference date will be determined once a definitive trial date is confirmed.

It’s important to note that the trial will not revisit the determination of the XRP token’s status as a security. Judge Torres has already ruled that it is not a security. Instead, the focus of the trial will be on whether Ripple’s top executives, Brad Garlinghouse and Chris Larsen, aided and abetted Ripple in selling unregistered securities.

The trial will solely address the specific allegations against Garlinghouse and Larsen. It will not reevaluate or debate any previously determined matters of law by Judge Torres.

Legal expert Jeremy Hogan believes that the final judgment in this case may not be reached until late summer 2024, and if there is an appeal, it could extend into 2025. Hogan suggests that the delays could actually work in favor of XRP and Ripple.

CryptoLaw US has clarified that the upcoming trial does not question the legal status of Ripple or the XRP token. It is purely focused on resolving the remaining disputed facts outlined in Judge Torres’ decision.

While the broader legal questions surrounding XRP have been settled, the scrutiny remains on the roles of key Ripple executives in this trial. The outcome of the trial will provide crucial clarity in this regard.